| Lindsay Vasil, CRNA | |
|
1513 E Jackson Blvd, Elkhart, IN 46516-4405 | |
| (574) 523-3193 | |
| Not Available |
| Full Name | Lindsay Vasil |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 8 Years |
| Location | 1513 E Jackson Blvd, Elkhart, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093169096 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 111581 (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Joseph Regional Medical Center | Mishawaka, IN | Hospital |
| Unity Medical And Surgical Hospital | Mishawaka, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| United Surgeons Llc | 0941260061 | 17 |
| Beacon Medical Group Inc | 1254243306 | 452 |
| Saint Joseph Regional Medical Center-south Bend Campus Inc | 3476451790 | 77 |
| The South Bend Clinic Llc | 3779577937 | 174 |
| Jebs Anesthesia Consultants, Llc | 4486046646 | 30 |
| Northern Indiana Anesthesia Associates, Llc | 6709234750 | 15 |
News Archive
Researchers have developed a new and easier method of detecting irregular heart rhythms such as Atrial Fibrillation (AF or AFib) after a stroke. At present clinical rely upon standard cardiac telemetry to detect AF seen commonly after a stroke.
Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.
The American Academy of Neurology, the American Brain Foundation and the Muscular Dystrophy Association have announced a new Clinical Research Training Fellowship in muscular dystrophy for 2017.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has issued an Approvable Letter for Solesta® as a treatment for fecal (bowel) incontinence.
› Verified 7 days ago
| Entity Name | Beacon Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033161617 PECOS PAC ID: 1254243306 Enrollment ID: O20031105000657 |
News Archive
Researchers have developed a new and easier method of detecting irregular heart rhythms such as Atrial Fibrillation (AF or AFib) after a stroke. At present clinical rely upon standard cardiac telemetry to detect AF seen commonly after a stroke.
Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.
The American Academy of Neurology, the American Brain Foundation and the Muscular Dystrophy Association have announced a new Clinical Research Training Fellowship in muscular dystrophy for 2017.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has issued an Approvable Letter for Solesta® as a treatment for fecal (bowel) incontinence.
› Verified 7 days ago
| Entity Name | Saint Joseph Regional Medical Center-south Bend Campus Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841245594 PECOS PAC ID: 3476451790 Enrollment ID: O20031223000724 |
News Archive
Researchers have developed a new and easier method of detecting irregular heart rhythms such as Atrial Fibrillation (AF or AFib) after a stroke. At present clinical rely upon standard cardiac telemetry to detect AF seen commonly after a stroke.
Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.
The American Academy of Neurology, the American Brain Foundation and the Muscular Dystrophy Association have announced a new Clinical Research Training Fellowship in muscular dystrophy for 2017.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has issued an Approvable Letter for Solesta® as a treatment for fecal (bowel) incontinence.
› Verified 7 days ago
| Entity Name | The South Bend Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073680419 PECOS PAC ID: 3779577937 Enrollment ID: O20040412000439 |
News Archive
Researchers have developed a new and easier method of detecting irregular heart rhythms such as Atrial Fibrillation (AF or AFib) after a stroke. At present clinical rely upon standard cardiac telemetry to detect AF seen commonly after a stroke.
Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.
The American Academy of Neurology, the American Brain Foundation and the Muscular Dystrophy Association have announced a new Clinical Research Training Fellowship in muscular dystrophy for 2017.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has issued an Approvable Letter for Solesta® as a treatment for fecal (bowel) incontinence.
› Verified 7 days ago
| Entity Name | Northern Indiana Anesthesia Services, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083639660 PECOS PAC ID: 1456321413 Enrollment ID: O20040727001614 |
News Archive
Researchers have developed a new and easier method of detecting irregular heart rhythms such as Atrial Fibrillation (AF or AFib) after a stroke. At present clinical rely upon standard cardiac telemetry to detect AF seen commonly after a stroke.
Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.
The American Academy of Neurology, the American Brain Foundation and the Muscular Dystrophy Association have announced a new Clinical Research Training Fellowship in muscular dystrophy for 2017.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has issued an Approvable Letter for Solesta® as a treatment for fecal (bowel) incontinence.
› Verified 7 days ago
| Entity Name | Stat Anesthesia Specialists Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699724781 PECOS PAC ID: 8123031473 Enrollment ID: O20070529000372 |
News Archive
Researchers have developed a new and easier method of detecting irregular heart rhythms such as Atrial Fibrillation (AF or AFib) after a stroke. At present clinical rely upon standard cardiac telemetry to detect AF seen commonly after a stroke.
Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.
The American Academy of Neurology, the American Brain Foundation and the Muscular Dystrophy Association have announced a new Clinical Research Training Fellowship in muscular dystrophy for 2017.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has issued an Approvable Letter for Solesta® as a treatment for fecal (bowel) incontinence.
› Verified 7 days ago
| Entity Name | United Surgeons Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518197011 PECOS PAC ID: 0941260061 Enrollment ID: O20110330000083 |
News Archive
Researchers have developed a new and easier method of detecting irregular heart rhythms such as Atrial Fibrillation (AF or AFib) after a stroke. At present clinical rely upon standard cardiac telemetry to detect AF seen commonly after a stroke.
Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.
The American Academy of Neurology, the American Brain Foundation and the Muscular Dystrophy Association have announced a new Clinical Research Training Fellowship in muscular dystrophy for 2017.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has issued an Approvable Letter for Solesta® as a treatment for fecal (bowel) incontinence.
› Verified 7 days ago
| Entity Name | Anesthesia Care Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073899449 PECOS PAC ID: 6608042288 Enrollment ID: O20120103000455 |
News Archive
Researchers have developed a new and easier method of detecting irregular heart rhythms such as Atrial Fibrillation (AF or AFib) after a stroke. At present clinical rely upon standard cardiac telemetry to detect AF seen commonly after a stroke.
Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.
The American Academy of Neurology, the American Brain Foundation and the Muscular Dystrophy Association have announced a new Clinical Research Training Fellowship in muscular dystrophy for 2017.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has issued an Approvable Letter for Solesta® as a treatment for fecal (bowel) incontinence.
› Verified 7 days ago
| Entity Name | Anesthesia Dynamics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073001012 PECOS PAC ID: 3779832530 Enrollment ID: O20191011000052 |
News Archive
Researchers have developed a new and easier method of detecting irregular heart rhythms such as Atrial Fibrillation (AF or AFib) after a stroke. At present clinical rely upon standard cardiac telemetry to detect AF seen commonly after a stroke.
Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.
The American Academy of Neurology, the American Brain Foundation and the Muscular Dystrophy Association have announced a new Clinical Research Training Fellowship in muscular dystrophy for 2017.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has issued an Approvable Letter for Solesta® as a treatment for fecal (bowel) incontinence.
› Verified 7 days ago
| Entity Name | Anesthesia Consulting And Clinical Specialists, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588246177 PECOS PAC ID: 1658770227 Enrollment ID: O20210602000536 |
News Archive
Researchers have developed a new and easier method of detecting irregular heart rhythms such as Atrial Fibrillation (AF or AFib) after a stroke. At present clinical rely upon standard cardiac telemetry to detect AF seen commonly after a stroke.
Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.
The American Academy of Neurology, the American Brain Foundation and the Muscular Dystrophy Association have announced a new Clinical Research Training Fellowship in muscular dystrophy for 2017.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has issued an Approvable Letter for Solesta® as a treatment for fecal (bowel) incontinence.
› Verified 7 days ago
| Entity Name | Sda Consultants Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336605500 PECOS PAC ID: 3870825912 Enrollment ID: O20210819003335 |
News Archive
Researchers have developed a new and easier method of detecting irregular heart rhythms such as Atrial Fibrillation (AF or AFib) after a stroke. At present clinical rely upon standard cardiac telemetry to detect AF seen commonly after a stroke.
Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.
The American Academy of Neurology, the American Brain Foundation and the Muscular Dystrophy Association have announced a new Clinical Research Training Fellowship in muscular dystrophy for 2017.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has issued an Approvable Letter for Solesta® as a treatment for fecal (bowel) incontinence.
› Verified 7 days ago
| Entity Name | Jebs Anesthesia Consultants, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790447761 PECOS PAC ID: 4486046646 Enrollment ID: O20220120000233 |
News Archive
Researchers have developed a new and easier method of detecting irregular heart rhythms such as Atrial Fibrillation (AF or AFib) after a stroke. At present clinical rely upon standard cardiac telemetry to detect AF seen commonly after a stroke.
Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.
The American Academy of Neurology, the American Brain Foundation and the Muscular Dystrophy Association have announced a new Clinical Research Training Fellowship in muscular dystrophy for 2017.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has issued an Approvable Letter for Solesta® as a treatment for fecal (bowel) incontinence.
› Verified 7 days ago
| Entity Name | Northern Indiana Anesthesia Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033891510 PECOS PAC ID: 6709234750 Enrollment ID: O20231130003347 |
News Archive
Researchers have developed a new and easier method of detecting irregular heart rhythms such as Atrial Fibrillation (AF or AFib) after a stroke. At present clinical rely upon standard cardiac telemetry to detect AF seen commonly after a stroke.
Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.
The American Academy of Neurology, the American Brain Foundation and the Muscular Dystrophy Association have announced a new Clinical Research Training Fellowship in muscular dystrophy for 2017.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has issued an Approvable Letter for Solesta® as a treatment for fecal (bowel) incontinence.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lindsay Vasil, CRNA 1513 E Jackson Blvd, Elkhart, IN 46516-4405 Ph: (574) 523-3193 | Lindsay Vasil, CRNA 1513 E Jackson Blvd, Elkhart, IN 46516-4405 Ph: (574) 523-3193 |
News Archive
Researchers have developed a new and easier method of detecting irregular heart rhythms such as Atrial Fibrillation (AF or AFib) after a stroke. At present clinical rely upon standard cardiac telemetry to detect AF seen commonly after a stroke.
Duchenne muscular dystrophy is a severely debilitating and lethal condition that affects 1 in 3,000. Females and males are affected, though females are rarely affected and are more often carriers. It is caused due to a defective gene that normally codes for the protein dystrophin, which helps provide a protective membrane around muscle fibers. Without this skin, muscle fibers become damaged and eventually die.
The American Academy of Neurology, the American Brain Foundation and the Muscular Dystrophy Association have announced a new Clinical Research Training Fellowship in muscular dystrophy for 2017.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has issued an Approvable Letter for Solesta® as a treatment for fecal (bowel) incontinence.
› Verified 7 days ago
Mr. Taqi Qays Abdu-as-salaam, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 500 N Nappanee St, Suite 11, Elkhart, IN 46514 Phone: 574-522-9922 | |
Mark Mcpherson, RN Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 600 East Blvd, Elkhart, IN 46514 Phone: 574-523-3193 | |
Ms. Barbara Ann Doherty, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1004 Parkway Ave, Suite B, Elkhart, IN 46516 Phone: 574-522-9922 Fax: 574-522-9926 | |
Naznin Lalani, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 500 N Nappanee, Ste 11b, Elkhart, IN 46514 Phone: 574-522-9922 | |
Joshua Stewart, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 600 East Blvd, Elkhart, IN 46514 Phone: 574-294-2621 | |
Denise Christine Brown, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 600 East Blvd, Elkhart, IN 46514 Phone: 574-523-3193 Fax: 574-523-3463 |